You just can’t see it yet because it’s NOT a banking, financial, or economic crisis… it’s far worse and threatens every dollar in your retirement account.

CERE Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.30%

Insider Buying (Last 12 Months): $49,875,000.00

Insider Selling (Last 12 Months): $13,772,097.40

Cerevel Therapeutics Insider Trading History Chart

Cerevel Therapeutics Share Price & Price History

^$34.43

▲ +1.49 (4.52%)

As of 01/27/2023 01:00 AM ET

Days: 30 | 90 | 365

The Next Big Crisis Is Here

From Porter & Company | Ad

You just can’t see it yet because it’s NOT a banking, financial, or economic crisis… it’s far worse and threatens every dollar in your retirement account.

Click here to watch it, free.

Cerevel Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/5/2023	N Anthony Coles	CEO	Sell	50,000	$29.94	$1,497,000.00	2,704
12/9/2022	N Anthony Coles	CEO	Sell	50,000	$26.67	$1,333,500.00	2,704
10/4/2022	John Renger	Insider	Sell	25,000	$30.00	$750,000.00	2,704
9/12/2022	Deval L. Patrick	Director	Sell	47,705	$30.78	$1,468,359.90
9/8/2022	Abraham Ceesay	President	Sell	19,210	$32.50	$624,325.00
8/22/2022	Abraham Ceesay	President	Sell	9,605	$32.50	$312,162.50
8/16/2022	Perceptive Advisors Llc	Director	Buy	1,425,000	$35.00	$49,875,000.00	6,511,727
8/10/2022	John Renger	Insider	Sell	55,000	$40.50	$2,227,500.00	2,704
7/20/2022	John Renger	Insider	Sell	25,000	$30.00	$750,000.00	2,704
7/5/2022	John Renger	Insider	Sell	25,000	$30.00	$750,000.00	2,704
4/13/2022	John Renger	Insider	Sell	45,000	$34.65	$1,559,250.00	1,980
3/29/2022	John Renger	Insider	Sell	10,000	$35.00	$350,000.00
3/18/2022	John Renger	Insider	Sell	20,000	$32.50	$650,000.00
3/16/2022	John Renger	Insider	Sell	25,000	$30.00	$750,000.00
2/9/2022	John Renger	Insider	Sell	25,000	$30.00	$750,000.00
12/27/2021	John Renger	Insider	Sell	4,127	$35.00	$144,445.00
12/23/2021	John Renger	Insider	Sell	5,873	$35.00	$205,555.00
12/21/2021	John Renger	Insider	Sell	7,300	$32.50	$237,250.00
12/17/2021	John Renger	Insider	Sell	7,122	$32.50	$231,465.00
12/15/2021	John Renger	Insider	Sell	25,000	$30.02	$750,500.00
11/10/2021	John Renger	Insider	Sell	55,000	$39.86	$2,192,300.00
8/25/2021	Perceptive Advisors Llc	Director	Buy	61,387	$28.57	$1,753,826.59
8/23/2021	Perceptive Advisors Llc	Director	Buy	44,437	$25.78	$1,145,585.86
7/7/2021	Perceptive Advisors Llc	Director	Buy	200,000	$25.00	$5,000,000.00
6/17/2021	Gabrielle Sulzberger	Director	Buy	21,084	$13.06	$275,357.04	35,354

Is This The End of Capitalism?

From Porter & Company | Ad

EXPOSED: The establishment plot to disenfranchise and impoverish millions of Americans…

click here now to get all the chilling details.

SEC Filings (Institutional Ownership Changes) for Cerevel Therapeutics (NASDAQ:CERE)

Institutional Buying and Selling by Quarter

Cerevel Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
12/8/2022	Bank of New York Mellon Corp	226,405	$6.40M	0.0%	+8.6%	0.145%
11/21/2022	California State Teachers Retirement System	72,499	$2.05M	0.0%	-1.4%	0.046%
11/16/2022	BNP Paribas Arbitrage SNC	61,985	$1.75M	0.0%	N/A	0.042%
11/15/2022	Alliancebernstein L.P.	67,200	$1.90M	0.0%	+7.0%	0.045%
11/15/2022	State Street Corp	2,719,272	$76.85M	0.0%	+12.6%	1.831%
11/15/2022	Twinbeech Capital LP	39,072	$1.10M	0.0%	N/A	0.026%
11/15/2022	UBS Asset Management Americas Inc.	49,968	$1.41M	0.0%	-19.7%	0.034%
11/15/2022	Vanguard Group Inc.	5,874,001	$166M	0.0%	+17.2%	3.956%
11/15/2022	Perceptive Advisors LLC	6,511,727	$184.02M	5.3%	+28.0%	4.385%
11/15/2022	Price T Rowe Associates Inc. MD	4,769,074	$134.78M	0.0%	-24.3%	3.211%
11/15/2022	Pura Vida Investments LLC	41,136	$1.16M	0.1%	-83.1%	0.028%
11/15/2022	Lord Abbett & CO. LLC	1,085,956	$30.69M	0.1%	+8.3%	0.731%
11/15/2022	Engineers Gate Manager LP	7,638	$0.22M	0.0%	N/A	0.005%
11/15/2022	Ensign Peak Advisors Inc	17,190	$0.49M	0.0%	+47.6%	0.012%
11/15/2022	Federated Hermes Inc.	3,313,333	$93.64M	0.3%	+6.4%	2.231%
11/15/2022	First Trust Advisors LP	58,934	$1.67M	0.0%	+60.3%	0.040%
11/15/2022	Bank of New York Mellon Corp	226,405	$6.40M	0.0%	+8.6%	0.152%
11/15/2022	BlackRock Inc.	4,188,371	$118.36M	0.0%	+1.4%	2.820%
11/14/2022	Royal Bank of Canada	2,959	$83K	0.0%	+19.4%	0.002%
11/14/2022	Point72 Hong Kong Ltd	1,470	$42K	0.0%	N/A	0.001%
11/14/2022	Point72 Asset Management L.P.	1,084,240	$30.64M	0.1%	+436.0%	0.730%
11/14/2022	Cubist Systematic Strategies LLC	33,207	$0.94M	0.0%	N/A	0.022%
11/14/2022	Verition Fund Management LLC	19,457	$0.55M	0.0%	N/A	0.013%
11/14/2022	Boothbay Fund Management LLC	33,959	$0.96M	0.0%	N/A	0.023%
11/14/2022	Nuveen Asset Management LLC	149,411	$4.22M	0.0%	-31.7%	0.101%
11/14/2022	AXA S.A.	147,533	$4.17M	0.0%	+17.9%	0.099%
11/14/2022	E Fund Management Co. Ltd.	10,400	$0.29M	0.0%	+22.6%	0.007%
11/10/2022	Credit Suisse AG	50,036	$1.42M	0.0%	+3.2%	0.034%
11/10/2022	Tower Research Capital LLC TRC	4,649	$0.13M	0.0%	-23.6%	0.003%
11/10/2022	UBS Group AG	19,081	$0.54M	0.0%	-63.6%	0.013%
11/10/2022	Finepoint Capital LP	536,901	$15.17M	5.0%	N/A	0.362%
11/8/2022	Camden Capital LLC	14,500	$0.41M	0.1%	N/A	0.010%
11/8/2022	New York State Common Retirement Fund	41,152	$1.16M	0.0%	+8.3%	0.028%
11/7/2022	TD Asset Management Inc.	185,544	$5.17M	0.0%	+1.4%	0.125%
11/4/2022	Prudential Financial Inc.	27,369	$0.77M	0.0%	+65.2%	0.018%
11/3/2022	Teacher Retirement System of Texas	19,432	$0.55M	0.0%	+109.1%	0.013%
11/3/2022	The Manufacturers Life Insurance Company	118,166	$3.30M	0.0%	+3.4%	0.080%
11/3/2022	Barclays PLC	97,735	$2.76M	0.0%	+3,371.9%	0.066%
11/2/2022	Victory Capital Management Inc.	17,793	$0.50M	0.0%	-8.7%	0.012%
11/1/2022	Tekla Capital Management LLC	176,483	$4.99M	0.2%	+100.2%	0.119%
10/31/2022	SG Americas Securities LLC	10,234	$0.29M	0.0%	-48.0%	0.007%
10/28/2022	State of New Jersey Common Pension Fund D	75,569	$2.14M	0.0%	N/A	0.051%
10/27/2022	Strs Ohio	3,900	$0.11M	0.0%	+143.8%	0.003%
10/24/2022	High Net Worth Advisory Group LLC	1,000	$28K	0.0%	N/A	0.001%
9/2/2022	Amundi	7,055	$0.19M	0.0%	N/A	0.005%
8/22/2022	Legal & General Group Plc	46,616	$1.23M	0.0%	+34.2%	0.031%
8/18/2022	Goldman Sachs Group Inc.	101,104	$2.67M	0.0%	+22.9%	0.068%
8/17/2022	Advisory Research Inc.	22,824	$0.60M	0.1%	-47.6%	0.015%
8/16/2022	Woodline Partners LP	255,533	$6.76M	0.1%	-29.4%	0.172%
8/16/2022	Price T Rowe Associates Inc. MD	6,295,908	$166.46M	0.0%	-2.8%	4.240%
8/16/2022	Prudential Financial Inc.	16,569	$0.44M	0.0%	+14.4%	0.011%
8/16/2022	Public Employees Retirement Association of Colorado	13,713	$0.36M	0.0%	N/A	0.009%
8/15/2022	AQR Capital Management LLC	22,653	$0.60M	0.0%	+143.8%	0.015%
8/15/2022	State Street Corp	2,414,474	$63.84M	0.0%	+11.7%	1.626%
8/15/2022	Point72 Asset Management L.P.	202,300	$5.35M	0.0%	N/A	0.136%
8/15/2022	Sei Investments Co.	11,131	$0.29M	0.0%	N/A	0.007%
8/15/2022	UBS Asset Management Americas Inc.	62,195	$1.64M	0.0%	+83.9%	0.042%
8/13/2022	American International Group Inc.	25,435	$0.67M	0.0%	+25.8%	0.017%
8/12/2022	Northern Trust Corp	501,877	$13.27M	0.0%	+22.2%	0.338%
8/12/2022	Virtus ETF Advisers LLC	4,259	$0.11M	0.0%	-18.3%	0.003%
8/12/2022	Credit Suisse AG	48,503	$1.28M	0.0%	+31.5%	0.033%
8/12/2022	Rafferty Asset Management LLC	73,978	$1.96M	0.0%	-34.5%	0.050%
8/12/2022	FMR LLC	22,243,384	$588.12M	0.1%	+0.2%	14.979%
8/12/2022	Rhumbline Advisers	62,367	$1.65M	0.0%	+51.9%	0.042%
8/11/2022	Deutsche Bank AG	32,187	$0.85M	0.0%	+22.0%	0.022%
8/11/2022	UBS Group AG	52,424	$1.39M	0.0%	+42.1%	0.035%
8/11/2022	Bank of Montreal Can	131,970	$3.70M	0.0%	N/A	0.089%
8/11/2022	Alps Advisors Inc.	87,969	$2.33M	0.0%	-42.2%	0.059%
8/11/2022	JPMorgan Chase & Co.	59,113	$1.56M	0.0%	+22.6%	0.040%
8/10/2022	Frazier Life Sciences Management L.P.	202,260	$5.35M	0.5%	+262.2%	0.136%
8/10/2022	Principal Financial Group Inc.	25,309	$0.67M	0.0%	+4.4%	0.017%
8/9/2022	Swiss National Bank	138,800	$3.67M	0.0%	+33.0%	0.093%
8/5/2022	State Board of Administration of Florida Retirement System	13,710	$0.36M	0.0%	N/A	0.009%
8/4/2022	TD Asset Management Inc.	183,008	$4.84M	0.0%	-6.5%	0.123%
8/3/2022	Nisa Investment Advisors LLC	1,380	$36K	0.0%	+46.8%	0.001%
8/3/2022	Candriam S.C.A.	397,221	$10.50M	0.1%	+57.9%	0.268%
8/3/2022	Handelsbanken Fonder AB	8,700	$0.23M	0.0%	-15.5%	0.006%
8/1/2022	Victory Capital Management Inc.	19,478	$0.52M	0.0%	+11.4%	0.013%
7/29/2022	Tekla Capital Management LLC	88,173	$2.33M	0.1%	+19.7%	0.059%
7/29/2022	SG Americas Securities LLC	19,671	$0.52M	0.0%	N/A	0.013%
7/28/2022	Arizona State Retirement System	15,960	$0.42M	0.0%	+33.7%	0.011%
7/26/2022	Mirae Asset Global Investments Co. Ltd.	15,677	$0.41M	0.0%	N/A	0.011%
6/30/2022	Amalgamated Bank	6,633	$0.23M	0.0%	-7.0%	0.004%
6/7/2022	Bank of America Corp DE	67,190	$2.35M	0.0%	-12.8%	0.045%
6/2/2022	Verition Fund Management LLC	82,135	$2.88M	0.0%	N/A	0.055%
5/20/2022	The Manufacturers Life Insurance Company	109,385	$3.70M	0.0%	+452.8%	0.074%
5/17/2022	Alyeska Investment Group L.P.	105,000	$3.68M	0.0%	N/A	0.071%
5/17/2022	Royal Bank of Canada	4,673	$0.16M	0.0%	-75.4%	0.003%
5/17/2022	Rock Springs Capital Management LP	1,723,341	$60.33M	1.5%	+4.5%	1.164%
5/16/2022	California State Teachers Retirement System	55,347	$1.94M	0.0%	-6.2%	0.037%
5/16/2022	Goldman Sachs Group Inc.	82,265	$2.88M	0.0%	-80.5%	0.056%
5/16/2022	Woodline Partners LP	361,753	$12.67M	0.2%	+52.4%	0.244%
5/16/2022	State Street Corp	2,162,096	$75.70M	0.0%	-2.5%	1.461%
5/16/2022	Frazier Life Sciences Management L.P.	55,835	$1.96M	0.2%	N/A	0.038%
5/16/2022	UBS Group AG	36,895	$1.29M	0.0%	-82.5%	0.025%
5/16/2022	Ally Bridge Group NY LLC	170,000	$5.95M	4.4%	N/A	0.115%
5/13/2022	Centaurus Financial Inc.	3,000	$0.11M	0.0%	N/A	0.002%
5/13/2022	Renaissance Technologies LLC	9,900	$0.35M	0.0%	N/A	0.007%
5/13/2022	Northern Trust Corp	410,618	$14.38M	0.0%	-3.8%	0.277%
5/13/2022	Verition Fund Management LLC	82,135	$2.88M	0.0%	N/A	0.055%

Data available starting January 2016

Cerevel Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, engages in the development of various therapies for neuroscience diseases. It is developing emraclidine, a positive allosteric modulator (PAM) that is in phase 1b clinical trials for the treatment of schizophrenia; and Darigabat, a PAM, which is in Phase 2 proof-of-concept trial in patients with drug-resistant focal onset seizures in epilepsy or focal epilepsy, as well as in phase 1 trial to treat acute anxiety. The company's products also comprise Tavapadon, a selective dopamine D1/D5 partial agonist that is in phase 3 clinical trial for the treatment of early- and late-stage Parkinson's disease; CVL-871, a selective dopamine D1/D5 partial agonist, which is in Phase 2a clinical trial to treat dementia-related apathy; CVL-936, a selective dopamine D3-preferring antagonist, which is in Phase I clinical trial for the treatment of substance use disorder; CVL-354, a selective kappa-opioid receptor antagonist to treat major depressive disorder and substance use disorder; and CVL-047, selective PDE4 inhibitor for the treatment of major depressive disorder and substance use disorder. It is also involved in the development of an M4 agonist program for the treatment of psychosis and related indications; and an LRRK2 inhibitor program to address disease progression in Parkinson's. The company was founded in 2018 and is headquartered in Cambridge, Massachusetts.

Today's Range

Now: $34.43

$32.96

$34.69

50 Day Range

MA: $30.12

$25.35

$34.43

52 Week Range

Now: $34.43

$19.86

$41.46

Volume

391,009 shs

Average Volume

432,378 shs

Market Capitalization

$5.38 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.47

Who are the company insiders with the largest holdings of Cerevel Therapeutics?: Cerevel Therapeutics' top insider investors include:
Perceptive Advisors Llc (Director)
Gabrielle Sulzberger (Director)
John Renger (Insider)
N Anthony Coles (CEO)
Abraham Ceesay (President)
Deval L Patrick (Director)
Learn More about top insider investors at Cerevel Therapeutics.